Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-08-28

AUTHORS

Markus Klinger, Mandy Kuhn, Herwig Just, Eduard Stefan, Timothy Palmer, Michael Freissmuth, Christian Nanoff

ABSTRACT

. The A2A-adenosine receptor has an extended carboxy terminus (~120 amino acids), the role of which is poorly defined. In human endothelial cells and in HEK293 cells, the A2A-receptor controls at least two independent signalling pathways, i.e. increased cyclic adenosine 3′,5′-monophosphate (cAMP) formation via its cognate G protein Gs and increased phosphorylation of mitogen-activated protein kinase (MAP kinase) by recruiting p21ras. In order to address the role of the carboxy terminus in signal transfer, we generated HEK293 cells that stably expressed the full-length (wt) receptor and truncated versions [A2A-R(1-360) and A2A-R(1-311)] at comparable levels (~0.5 pmol/mg) in the plasma membrane. The effects of truncation were divergent with respect to the two effectors regulated by the receptor. In intact cells carrying A2A-R(wt) and A2A-R(1-360), cAMP accumulation was more potently activated by an A2A-agonist than in cells expressing A2A-R(1-311). Similarly, A2A-R(wt) and A2A-R(1-360) – but not A2A-R(1-311) – caused constitutive (=agonist-independent) elevation of cAMP which was reversed by the addition of A2A-antagonists. In membranes prepared from these cells, however, the three receptors displayed no constitutive activity in stimulating adenylyl cyclase and they did not differ in apparent agonist affinity. Truncation of the A2A-receptor did also not decrease the potency of an A2A-agonist to stimulate MAP kinase in intact cells. We conclude that the carboxy terminus defines both (a) the level of constitutive activity, i.e. the equilibrium R↔R*, in intact cells only, indicating a role for a component that is lost upon cell lysis, and (b) the efficiency of signal transfer in alternative pathways. More... »

PAGES

287-298

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00210-002-0617-z

DOI

http://dx.doi.org/10.1007/s00210-002-0617-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015763478

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12237741


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic AMP", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitogen-Activated Protein Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Purinergic P1 Receptor Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Adenosine A2A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Purinergic P1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transfection", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klinger", 
        "givenName": "Markus", 
        "id": "sg:person.01264677215.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264677215.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuhn", 
        "givenName": "Mandy", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Just", 
        "givenName": "Herwig", 
        "id": "sg:person.0703060126.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703060126.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stefan", 
        "givenName": "Eduard", 
        "id": "sg:person.01154263224.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154263224.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, University of Glasgow, Glasgow G12 8QQ, Scotland", 
          "id": "http://www.grid.ac/institutes/grid.8756.c", 
          "name": [
            "Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, University of Glasgow, Glasgow G12 8QQ, Scotland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmer", 
        "givenName": "Timothy", 
        "id": "sg:person.01121154220.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121154220.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Freissmuth", 
        "givenName": "Michael", 
        "id": "sg:person.01323136363.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323136363.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Institute of Pharmacology, University of Vienna, W\u00e4hringer Strasse 13a, 1090 Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nanoff", 
        "givenName": "Christian", 
        "id": "sg:person.01036057403.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036057403.99"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-08-28", 
    "datePublishedReg": "2002-08-28", 
    "description": "Abstract. The A2A-adenosine receptor has an extended carboxy terminus (~120 amino acids), the role of which is poorly defined. In human endothelial cells and in HEK293 cells, the A2A-receptor controls at least two independent signalling pathways, i.e. increased cyclic adenosine 3\u2032,5\u2032-monophosphate (cAMP) formation via its cognate G protein Gs and increased phosphorylation of mitogen-activated protein kinase (MAP kinase) by recruiting p21ras. In order to address the role of the carboxy terminus in signal transfer, we generated HEK293 cells that stably expressed the full-length (wt) receptor and truncated versions [A2A-R(1-360) and A2A-R(1-311)] at comparable levels (~0.5\u00a0pmol/mg) in the plasma membrane. The effects of truncation were divergent with respect to the two effectors regulated by the receptor. In intact cells carrying A2A-R(wt) and A2A-R(1-360), cAMP accumulation was more potently activated by an A2A-agonist than in cells expressing A2A-R(1-311). Similarly, A2A-R(wt) and A2A-R(1-360) \u2013 but not A2A-R(1-311) \u2013 caused constitutive (=agonist-independent) elevation of cAMP which was reversed by the addition of A2A-antagonists. In membranes prepared from these cells, however, the three receptors displayed no constitutive activity in stimulating adenylyl cyclase and they did not differ in apparent agonist affinity. Truncation of the A2A-receptor did also not decrease the potency of an A2A-agonist to stimulate MAP kinase in intact cells. We conclude that the carboxy terminus defines both (a) the level of constitutive activity, i.e. the equilibrium R\u2194R*, in intact cells only, indicating a role for a component that is lost upon cell lysis, and (b) the efficiency of signal transfer in alternative pathways.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00210-002-0617-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015404", 
        "issn": [
          "0028-1298", 
          "1432-1912"
        ], 
        "name": "Naunyn-Schmiedeberg's Archives of Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "366"
      }
    ], 
    "keywords": [
      "carboxy terminus", 
      "intact cells", 
      "constitutive activity", 
      "HEK293 cells", 
      "mitogen-activated protein kinase", 
      "MAP kinase stimulation", 
      "full-length receptor", 
      "G protein Gs", 
      "kinase stimulation", 
      "protein kinase", 
      "plasma membrane", 
      "signal transfer", 
      "human endothelial cells", 
      "constitutive elevation", 
      "protein Gs", 
      "terminus", 
      "apparent agonist affinity", 
      "cAMP accumulation", 
      "adenylyl cyclase", 
      "cell lysis", 
      "cyclic adenosine", 
      "alternative pathway", 
      "cells", 
      "endothelial cells", 
      "pathway", 
      "receptors", 
      "membrane", 
      "agonist affinity", 
      "p21ras", 
      "accumulation", 
      "kinase", 
      "phosphorylation", 
      "truncation", 
      "effectors", 
      "comparable levels", 
      "role", 
      "A2A adenosine receptors", 
      "activity", 
      "differential effects", 
      "monophosphate formation", 
      "cyclase", 
      "GS", 
      "cAMP", 
      "affinity", 
      "lysis", 
      "levels", 
      "A2A", 
      "effect of truncation", 
      "adenosine", 
      "stimulation", 
      "formation", 
      "potency", 
      "transfer", 
      "effect", 
      "components", 
      "addition", 
      "maps", 
      "elevation", 
      "control", 
      "removal", 
      "blunt", 
      "respect", 
      "equilibrium", 
      "efficiency", 
      "order", 
      "version"
    ], 
    "name": "Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation", 
    "pagination": "287-298", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015763478"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00210-002-0617-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12237741"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00210-002-0617-z", 
      "https://app.dimensions.ai/details/publication/pub.1015763478"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_349.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00210-002-0617-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0617-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0617-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0617-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0617-z'


 

This table displays all metadata directly associated to this object as RDF triples.

216 TRIPLES      21 PREDICATES      103 URIs      94 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00210-002-0617-z schema:about N32d25a0504ca4eb7a5df50e3fff55a40
2 N36c57b030e21480587172872898e5df6
3 N51aaa5b9ca374c25be20aeeb1f0d8a0e
4 N78d3291bb69344298a72dae2e82eac07
5 N7a16d2f72e69449aabb5fd3b09fd83f8
6 Na7abb9b04f54496dac379e2ceef56586
7 Nc317114ba16a453393af11276f76e43e
8 Nebbe5e0f7d1e480db26466ae57f0ca10
9 Nf046658925044f5887c59b6c1ba7c196
10 Nf533b472161f4b9f8c873739989d1fd7
11 anzsrc-for:11
12 anzsrc-for:1115
13 anzsrc-for:1116
14 schema:author N9faded6c82d94cfabb7fb1606d30f7c7
15 schema:datePublished 2002-08-28
16 schema:datePublishedReg 2002-08-28
17 schema:description Abstract. The A2A-adenosine receptor has an extended carboxy terminus (~120 amino acids), the role of which is poorly defined. In human endothelial cells and in HEK293 cells, the A2A-receptor controls at least two independent signalling pathways, i.e. increased cyclic adenosine 3′,5′-monophosphate (cAMP) formation via its cognate G protein Gs and increased phosphorylation of mitogen-activated protein kinase (MAP kinase) by recruiting p21ras. In order to address the role of the carboxy terminus in signal transfer, we generated HEK293 cells that stably expressed the full-length (wt) receptor and truncated versions [A2A-R(1-360) and A2A-R(1-311)] at comparable levels (~0.5 pmol/mg) in the plasma membrane. The effects of truncation were divergent with respect to the two effectors regulated by the receptor. In intact cells carrying A2A-R(wt) and A2A-R(1-360), cAMP accumulation was more potently activated by an A2A-agonist than in cells expressing A2A-R(1-311). Similarly, A2A-R(wt) and A2A-R(1-360) – but not A2A-R(1-311) – caused constitutive (=agonist-independent) elevation of cAMP which was reversed by the addition of A2A-antagonists. In membranes prepared from these cells, however, the three receptors displayed no constitutive activity in stimulating adenylyl cyclase and they did not differ in apparent agonist affinity. Truncation of the A2A-receptor did also not decrease the potency of an A2A-agonist to stimulate MAP kinase in intact cells. We conclude that the carboxy terminus defines both (a) the level of constitutive activity, i.e. the equilibrium R↔R*, in intact cells only, indicating a role for a component that is lost upon cell lysis, and (b) the efficiency of signal transfer in alternative pathways.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N3cc34741f42b43a88a98c1d67a8dca35
22 Nfa32d7660aa84a93ab74923dd908b897
23 sg:journal.1015404
24 schema:keywords A2A
25 A2A adenosine receptors
26 G protein Gs
27 GS
28 HEK293 cells
29 MAP kinase stimulation
30 accumulation
31 activity
32 addition
33 adenosine
34 adenylyl cyclase
35 affinity
36 agonist affinity
37 alternative pathway
38 apparent agonist affinity
39 blunt
40 cAMP
41 cAMP accumulation
42 carboxy terminus
43 cell lysis
44 cells
45 comparable levels
46 components
47 constitutive activity
48 constitutive elevation
49 control
50 cyclase
51 cyclic adenosine
52 differential effects
53 effect
54 effect of truncation
55 effectors
56 efficiency
57 elevation
58 endothelial cells
59 equilibrium
60 formation
61 full-length receptor
62 human endothelial cells
63 intact cells
64 kinase
65 kinase stimulation
66 levels
67 lysis
68 maps
69 membrane
70 mitogen-activated protein kinase
71 monophosphate formation
72 order
73 p21ras
74 pathway
75 phosphorylation
76 plasma membrane
77 potency
78 protein Gs
79 protein kinase
80 receptors
81 removal
82 respect
83 role
84 signal transfer
85 stimulation
86 terminus
87 transfer
88 truncation
89 version
90 schema:name Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation
91 schema:pagination 287-298
92 schema:productId N010501046ab9436c97566fe48a068697
93 N5c8afb60e3d5459a9ef6cba19c5e84fd
94 Nfb4a6d84fd914612bc048260ab502d9b
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015763478
96 https://doi.org/10.1007/s00210-002-0617-z
97 schema:sdDatePublished 2022-05-20T07:21
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher Nda643736046943f898781a9d2bfb465f
100 schema:url https://doi.org/10.1007/s00210-002-0617-z
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N010501046ab9436c97566fe48a068697 schema:name pubmed_id
105 schema:value 12237741
106 rdf:type schema:PropertyValue
107 N0a7d9411965d4c2ca103e7f8e14025f1 schema:affiliation grid-institutes:grid.10420.37
108 schema:familyName Kuhn
109 schema:givenName Mandy
110 rdf:type schema:Person
111 N32d25a0504ca4eb7a5df50e3fff55a40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Cell Line
113 rdf:type schema:DefinedTerm
114 N36c57b030e21480587172872898e5df6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Receptors, Purinergic P1
116 rdf:type schema:DefinedTerm
117 N3cc34741f42b43a88a98c1d67a8dca35 schema:issueNumber 4
118 rdf:type schema:PublicationIssue
119 N51aaa5b9ca374c25be20aeeb1f0d8a0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Mitogen-Activated Protein Kinases
121 rdf:type schema:DefinedTerm
122 N5c8afb60e3d5459a9ef6cba19c5e84fd schema:name dimensions_id
123 schema:value pub.1015763478
124 rdf:type schema:PropertyValue
125 N6bae6d16bf854281aac6e6951e0aab0f rdf:first sg:person.01323136363.60
126 rdf:rest N8586caed387a43b099f2592905eba453
127 N71606988a1f4443dbce05ba1ca485f80 rdf:first N0a7d9411965d4c2ca103e7f8e14025f1
128 rdf:rest Nf904483a3174495ca2da3606bf205249
129 N78d3291bb69344298a72dae2e82eac07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cyclic AMP
131 rdf:type schema:DefinedTerm
132 N7a16d2f72e69449aabb5fd3b09fd83f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Signal Transduction
134 rdf:type schema:DefinedTerm
135 N8586caed387a43b099f2592905eba453 rdf:first sg:person.01036057403.99
136 rdf:rest rdf:nil
137 N9faded6c82d94cfabb7fb1606d30f7c7 rdf:first sg:person.01264677215.80
138 rdf:rest N71606988a1f4443dbce05ba1ca485f80
139 Na7abb9b04f54496dac379e2ceef56586 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Purinergic P1 Receptor Antagonists
141 rdf:type schema:DefinedTerm
142 Na9578cfa1b5a4bc3862b72a5c0db0a32 rdf:first sg:person.01154263224.94
143 rdf:rest Ne668ab573cb64dd8bb243483daae297c
144 Nc317114ba16a453393af11276f76e43e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Dose-Response Relationship, Drug
146 rdf:type schema:DefinedTerm
147 Nda643736046943f898781a9d2bfb465f schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 Ne668ab573cb64dd8bb243483daae297c rdf:first sg:person.01121154220.12
150 rdf:rest N6bae6d16bf854281aac6e6951e0aab0f
151 Nebbe5e0f7d1e480db26466ae57f0ca10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Receptor, Adenosine A2A
153 rdf:type schema:DefinedTerm
154 Nf046658925044f5887c59b6c1ba7c196 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 Nf533b472161f4b9f8c873739989d1fd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Transfection
159 rdf:type schema:DefinedTerm
160 Nf904483a3174495ca2da3606bf205249 rdf:first sg:person.0703060126.63
161 rdf:rest Na9578cfa1b5a4bc3862b72a5c0db0a32
162 Nfa32d7660aa84a93ab74923dd908b897 schema:volumeNumber 366
163 rdf:type schema:PublicationVolume
164 Nfb4a6d84fd914612bc048260ab502d9b schema:name doi
165 schema:value 10.1007/s00210-002-0617-z
166 rdf:type schema:PropertyValue
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
171 schema:name Pharmacology and Pharmaceutical Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical Physiology
175 rdf:type schema:DefinedTerm
176 sg:journal.1015404 schema:issn 0028-1298
177 1432-1912
178 schema:name Naunyn-Schmiedeberg's Archives of Pharmacology
179 schema:publisher Springer Nature
180 rdf:type schema:Periodical
181 sg:person.01036057403.99 schema:affiliation grid-institutes:grid.10420.37
182 schema:familyName Nanoff
183 schema:givenName Christian
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036057403.99
185 rdf:type schema:Person
186 sg:person.01121154220.12 schema:affiliation grid-institutes:grid.8756.c
187 schema:familyName Palmer
188 schema:givenName Timothy
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121154220.12
190 rdf:type schema:Person
191 sg:person.01154263224.94 schema:affiliation grid-institutes:grid.10420.37
192 schema:familyName Stefan
193 schema:givenName Eduard
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154263224.94
195 rdf:type schema:Person
196 sg:person.01264677215.80 schema:affiliation grid-institutes:grid.10420.37
197 schema:familyName Klinger
198 schema:givenName Markus
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264677215.80
200 rdf:type schema:Person
201 sg:person.01323136363.60 schema:affiliation grid-institutes:grid.10420.37
202 schema:familyName Freissmuth
203 schema:givenName Michael
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323136363.60
205 rdf:type schema:Person
206 sg:person.0703060126.63 schema:affiliation grid-institutes:grid.10420.37
207 schema:familyName Just
208 schema:givenName Herwig
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703060126.63
210 rdf:type schema:Person
211 grid-institutes:grid.10420.37 schema:alternateName Institute of Pharmacology, University of Vienna, Währinger Strasse 13a, 1090 Vienna, Austria
212 schema:name Institute of Pharmacology, University of Vienna, Währinger Strasse 13a, 1090 Vienna, Austria
213 rdf:type schema:Organization
214 grid-institutes:grid.8756.c schema:alternateName Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, University of Glasgow, Glasgow G12 8QQ, Scotland
215 schema:name Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, University of Glasgow, Glasgow G12 8QQ, Scotland
216 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...